ArticleHepatology international2021

Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwan.

Fu-Shun Yen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.